Conference Proceedings

TOLERATING A DEGREE OF SUBRETINAL FLUID IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) WITH RANIBIZUMAB USING A TREAT AND EXTEND REGIMEN: 24 MONTH RESULTS FROM THE PHASE IV, RANDOMISED, SINGLE-MASKED, MULTI-CENTRE FLUID STUDY

Robyn AM Guymer, Caroline Markey, Ian McAllister, Mark Gillies, Alex Hunyor, Jennifer Arnold

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | WILEY | Published : 2018